tiprankstipranks
Trending News
More News >
Precipio Inc (PRPO)
NASDAQ:PRPO

Precipio (PRPO) Price & Analysis

Compare
435 Followers

PRPO Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

12.86%2.07%2.53%81.37%
12.86% Insiders
2.53% Other Institutional Investors
81.37% Public Companies and
Individual Investors

PRPO FAQ

What was Precipio Inc’s price range in the past 12 months?
Precipio Inc lowest stock price was $3.90 and its highest was $11.80 in the past 12 months.
    What is Precipio Inc’s market cap?
    Precipio Inc’s market cap is $16.43M.
      When is Precipio Inc’s upcoming earnings report date?
      Precipio Inc’s upcoming earnings report date is Aug 25, 2025 which is in 54 days.
        How were Precipio Inc’s earnings last quarter?
        Currently, no data Available
        Is Precipio Inc overvalued?
        According to Wall Street analysts Precipio Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Precipio Inc pay dividends?
          Precipio Inc does not currently pay dividends.
          What is Precipio Inc’s EPS estimate?
          Precipio Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Precipio Inc have?
          Precipio Inc has 1,512,011 shares outstanding.
            What happened to Precipio Inc’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Precipio Inc?
            Currently, no hedge funds are holding shares in PRPO

            Company Description

            Precipio Inc

            Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.

            PRPO Earnings Call

            Q1 2025
            0:00 / 0:00
            Earnings Call Sentiment|Positive
            The earnings call highlighted strong year-over-year revenue growth, improved margins, and significant operational efficiency gains. However, these positives were somewhat offset by a quarter-over-quarter revenue decline, delays in product division revenue realization, and initial uncertainty regarding FDA regulations. Despite these challenges, the overall sentiment remains cautiously optimistic, with expectations of continued growth and positive cash flow in the coming quarters.Read More>
            Similar Stocks
            Company
            Price & Change
            Follow
            Neurometrix
            Eterna Therapeutics
            Kiora Pharmaceuticals
            Lyra Therapeutics
            Acurx Pharmaceuticals
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis